Literature DB >> 31603304

Intrathecal Administration of Nanoclusters for Protecting Neurons against Oxidative Stress in Cerebral Ischemia/Reperfusion Injury.

Shiyong Li1,2, Dawei Jiang2, Emily B Ehlerding2, Zachary T Rosenkrans2, Jonathan W Engle2, Ye Wang3, Huisheng Liu4, Dalong Ni2, Weibo Cai2.   

Abstract

Oxidative stress is one of the important mechanisms in cerebral ischemia/reperfusion (I/R) injury. Antioxidants with high brain accumulation are highly desired to help prevent cerebral I/R injury. Herein, intrathecal injection of polyoxometalate (POM) nanoclusters as nano-antioxidants with preferential brain uptake were applied for neuronal protection in cerebral I/R injury. Using powerful positron emission tomography imaging, the uptake of nano-antioxidants in the brain was non-invasively and real-timely monitored. Our results demonstrated that POM nanoclusters rapidly reached the ischemic penumbra after intrathecal injection and effectively scavenged reactive oxygen species (ROS) for inhibiting oxidative stress. The infarct size was reduced, and neurological function was restored in cerebral I/R injury rat models. As a proof-of-concept, the intrathecal injection of nano-antioxidants is an excellent therapeutic strategy to ameliorate cerebral I/R injury.

Entities:  

Keywords:  cerebral ischemia/reperfusion injury; intrathecal injection; nano-antioxidants; oxidative stress; positron emission tomography

Year:  2019        PMID: 31603304      PMCID: PMC6881527          DOI: 10.1021/acsnano.9b06780

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  40 in total

1.  Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition.

Authors:  D A Judd; J H Nettles; N Nevins; J P Snyder; D C Liotta; J Tang; J Ermolieff; R F Schinazi; C L Hill
Journal:  J Am Chem Soc       Date:  2001-02-07       Impact factor: 15.419

2.  Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Authors:  Opeolu Adeoye; Richard Hornung; Pooja Khatri; Dawn Kleindorfer
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

Review 3.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

Review 4.  Diffusion of macromolecules in the brain: implications for drug delivery.

Authors:  Daniel J Wolak; Robert G Thorne
Journal:  Mol Pharm       Date:  2013-01-31       Impact factor: 4.939

5.  Advances in stroke therapy.

Authors:  Hayder Jaffer; Viola B Morris; Desiree Stewart; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2011-12-01       Impact factor: 4.617

6.  Nano-Curcumin Simultaneously Protects the Blood-Brain Barrier and Reduces M1 Microglial Activation During Cerebral Ischemia-Reperfusion Injury.

Authors:  Ye Wang; Jun Luo; Shi-Yong Li
Journal:  ACS Appl Mater Interfaces       Date:  2019-01-22       Impact factor: 9.229

Review 7.  Physical, Chemical, and Biological Structures based on ROS-Sensitive Moieties that are Able to Respond to Oxidative Microenvironments.

Authors:  Christos Tapeinos; Abhay Pandit
Journal:  Adv Mater       Date:  2016-05-17       Impact factor: 30.849

8.  Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion.

Authors:  Sònia Solé; Valérie Petegnief; Roser Gorina; Angel Chamorro; Anna M Planas
Journal:  J Neuropathol Exp Neurol       Date:  2004-04       Impact factor: 3.685

Review 9.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Magdalena Hofer
Journal:  J Transl Med       Date:  2009-11-17       Impact factor: 5.531

Review 10.  Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies.

Authors:  Wenjun Li; Shaohua Yang
Journal:  Brain Circ       Date:  2016-12-06
View more
  8 in total

1.  Ameliorating Effect of Umbilical Cord Mesenchymal Stem Cells in a Human Induced Pluripotent Stem Cell Model of Dravet Syndrome.

Authors:  Huifang Zhao; Shuai Li; Lang He; Feng Tang; Xiaobo Han; Weiyue Deng; Zuoxian Lin; Rongqi Huang; Zhiyuan Li
Journal:  Mol Neurobiol       Date:  2021-11-11       Impact factor: 5.590

Review 2.  Intertwined Relation between the Endoplasmic Reticulum and Mitochondria in Ischemic Stroke.

Authors:  Jianhua Peng; Dipritu Ghosh; Jinwei Pang; Lifang Zhang; Shigang Yin; Yong Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-04-28       Impact factor: 7.310

Review 3.  Nanomaterials alleviating redox stress in neurological diseases: mechanisms and applications.

Authors:  Yanping Jiang; Yiyuan Kang; Jia Liu; Suhan Yin; Zhendong Huang; Longquan Shao
Journal:  J Nanobiotechnology       Date:  2022-06-07       Impact factor: 9.429

Review 4.  Activatable Second Near-Infrared Fluorescent Probes: A New Accurate Diagnosis Strategy for Diseases.

Authors:  Dong Li; Jie Pan; Shuyu Xu; Shiying Fu; Chengchao Chu; Gang Liu
Journal:  Biosensors (Basel)       Date:  2021-11-02

Review 5.  Nanozymes-recent development and biomedical applications.

Authors:  Xiangyi Ren; Dongxu Chen; Yan Wang; Huifang Li; Yabing Zhang; Hongying Chen; Xi Li; Minfeng Huo
Journal:  J Nanobiotechnology       Date:  2022-02-22       Impact factor: 10.435

Review 6.  Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives.

Authors:  Shin Hyuk Yoo; Hae-Won Kim; Jun Hee Lee
Journal:  J Tissue Eng       Date:  2022-03-23       Impact factor: 7.813

Review 7.  Potential nanotherapeutic strategies for perioperative stroke.

Authors:  Jingyi An; Ling Zhao; Ranran Duan; Ke Sun; Wenxin Lu; Jiali Yang; Yan Liang; Junjie Liu; Zhenzhong Zhang; Li Li; Jinjin Shi
Journal:  CNS Neurosci Ther       Date:  2022-03-04       Impact factor: 5.243

8.  SET domain containing 7 promotes oxygen-glucose deprivation/reoxygenation-induced PC12 cell inflammation and oxidative stress by regulating Keap1/Nrf2/ARE and NF-κB pathways.

Authors:  Xianfang Pan; Jin Fan; Fang Peng; Li Xiao; Zhiyi Yang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.